INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $253,000 | – | 1,125,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 1,125,000 | $253,000 | 0.23% |
| IMS Capital Management | 23,472 | $5,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 181 | $0 | 0.00% |
| UBS Group AG | 44,664 | $10,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 2 | $0 | 0.00% |
| Advisor Group, Inc. | 785 | $0 | 0.00% |
| Jacobi Capital Management LLC | 20 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 65 | $0 | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 3 | $0 | 0.00% |